Oklo Inc.(股票代码:OKLO)今日盘中大涨5.13%,引起市场广泛关注。
消息面上,Oklo Inc.与美国能源创新机构Doe宣布达成战略合作,将共同建设放射性同位素试点生产设施。该设施旨在规模化生产医用放射性同位素,重点支持癌症精准治疗领域,同时强化美国本土医疗供应链的稳定性。这一合作进一步巩固了Oklo在先进核能技术领域的领先地位,并为其开辟了新的市场增长点。
Oklo Inc.(股票代码:OKLO)今日盘中大涨5.13%,引起市场广泛关注。
消息面上,Oklo Inc.与美国能源创新机构Doe宣布达成战略合作,将共同建设放射性同位素试点生产设施。该设施旨在规模化生产医用放射性同位素,重点支持癌症精准治疗领域,同时强化美国本土医疗供应链的稳定性。这一合作进一步巩固了Oklo在先进核能技术领域的领先地位,并为其开辟了新的市场增长点。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.